Evidence-based guidelines for interpretation of the Panic Disorder Severity Scale
- PMID: 19006198
- PMCID: PMC2760657
- DOI: 10.1002/da.20532
Evidence-based guidelines for interpretation of the Panic Disorder Severity Scale
Abstract
Background: The Panic Disorder Severity Scale (PDSS) is promising to be a standard global rating scale for panic disorder. In order for a clinical scale to be useful, we need a guideline for interpreting its scores and their changes, and for defining clinical change points such as response and remission.
Methods: We used individual patient data from two large randomized controlled trials of panic disorder (total n=568). Study participants were administered the PDSS and the Clinical Global Impression (CGI)--Severity and --Improvement. We applied equipercentile linking technique to draw correspondences between PDSS and CGI-Severity, numeric changes in PDSS and CGI-Improvement, and percent changes in PDSS and CGI-Improvement.
Results: The interpretation of the PDSS total score differed according to the presence or absence of agoraphobia. When the patients were not agoraphobic, score ranges 0-1 corresponded with "Normal," 2-5 with "Borderline," 6-9 with "Slightly ill," 10-13 with "Moderately ill," and 14 and above with "Markedly ill." When the patients were agoraphobic, score ranges 3-7 meant "Borderline ill," 8-10 "Slightly ill," 11-15 "Moderately ill," and 16 and above "Markedly ill." The relationship between PDSS change and CGI-Improvement was more linear when measured as percentile change than as numeric changes, and was indistinguishable for those with or without agoraphobia. The decrease by 75-100% was considered "Very much improved," that by 40-74% "Much improved," and that by 10-39% "Minimally improved."
Conclusion: We propose that "remission" of panic disorder be defined by PDSS scores of five or less and its "response" by 40% or greater reduction.
Figures
Similar articles
-
The use of the Panic and Agoraphobia Scale in a clinical trial.Psychiatry Res. 1998 Jan 16;77(1):43-9. doi: 10.1016/s0165-1781(97)00118-2. Psychiatry Res. 1998. PMID: 10710174 Clinical Trial.
-
Cognitive-behavioral therapy, imipramine, or their combination for panic disorder: A randomized controlled trial.JAMA. 2000 May 17;283(19):2529-36. doi: 10.1001/jama.283.19.2529. JAMA. 2000. PMID: 10815116 Clinical Trial.
-
Treatment of panic disorder with agoraphobia: randomized placebo-controlled trial of four psychosocial treatments combined with imipramine or placebo.Cogn Behav Ther. 2008;37(3):146-59. doi: 10.1080/16506070701743120. Cogn Behav Ther. 2008. PMID: 18608313 Clinical Trial.
-
The panic-agoraphobic spectrum: a descriptive approach to the assessment and treatment of subtle symptoms.Am J Psychiatry. 1997 Jun;154(6 Suppl):27-38. doi: 10.1176/ajp.154.6.27. Am J Psychiatry. 1997. PMID: 9167542 Review.
-
Course and outcome in panic disorder: a review of recent follow-up studies.Anxiety. 1994-1995;1(4):151-60. doi: 10.1002/anxi.3070010402. Anxiety. 1994. PMID: 9160567 Review.
Cited by
-
The interplay between sexual abuse and inflammation, oxidative stress, and DNA damage in drug-naïve panic disorder patients.Mol Psychiatry. 2023 Jul;28(7):2995-3001. doi: 10.1038/s41380-023-02086-z. Epub 2023 May 2. Mol Psychiatry. 2023. PMID: 37131075
-
Pharmacological treatments in panic disorder in adults: a network meta-analysis.Cochrane Database Syst Rev. 2023 Nov 28;11(11):CD012729. doi: 10.1002/14651858.CD012729.pub3. Cochrane Database Syst Rev. 2023. PMID: 38014714 Free PMC article.
-
Choosing the right treatment - combining clinicians' expert knowledge with data-driven predictions.Front Psychiatry. 2024 Sep 3;15:1422587. doi: 10.3389/fpsyt.2024.1422587. eCollection 2024. Front Psychiatry. 2024. PMID: 39290309 Free PMC article.
-
Processes of therapeutic change: Results from the Cornell-Penn Study of Psychotherapies for Panic Disorder.J Couns Psychol. 2020 Mar;67(2):222-231. doi: 10.1037/cou0000417. J Couns Psychol. 2020. PMID: 32105128 Free PMC article.
-
Altered Low Frequency Heart Rate Variability Associated with Agoraphobia in Panic Disorder: A Retrospective Study.Yonsei Med J. 2023 Nov;64(11):670-678. doi: 10.3349/ymj.2022.0592. Yonsei Med J. 2023. PMID: 37880848 Free PMC article.
References
-
- Shear MK, Maser JD. Standardized assessment for panic disorder research. A conference report. Arch Gen Psychiatry. 1994;51:346–354. - PubMed
-
- Weise RE, Shear MK, Maser JD. On the need for standardization in panic disorder treatment research: survey of the literature, 1980–1992. Anxiety. 1996;2:257–264. - PubMed
-
- Shear MK, Brown TA, Barlow DH, et al. Multicenter collaborative panic disorder severity scale. Am J Psychiatry. 1997;154:1571–1575. - PubMed
-
- Shear MK, Barlow D, Brown T, et al. Panic Disorder Severity Scale (PDSS) In: Rush AJ, First MB, Blacker D, editors. Handbook of Psychiatric Measures. 2. Washington, D.C: American Psychiatric Association; 2007. pp. 542–543.
-
- Goodman WK, Price LH, Rasmussen SA, et al. The Yale-Brown Obsessive Compulsive Scale. I Development, use, and reliability. Arch Gen Psychiatry. 1989;46:1006–1011. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical